[{"NetIncomeLoss_1_Q2_USD":-3297800.0,"DepreciationAndAmortization_2_Q2_USD":50900.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1269500.0,"GeneralAndAdministrativeExpense_2_Q2_USD":2660100.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":67082935.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":59245209.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":1600.0,"LiabilitiesNoncurrent_0_Q2_USD":12746200.0,"AccruedLiabilitiesCurrent_0_Q2_USD":186900.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":1931400.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":3500.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":7100.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-98800.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":12905100.0,"CapitalLeasedAssetsGross_0_Q2_USD":14700.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":766000.0,"AssetsCurrent_0_Q2_USD":15972100.0,"TreasuryStockShares_0_Q2_shares":135665.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":42058174.0,"TreasuryStockValue_0_Q2_USD":3968100.0,"DeferredPolicyAcquisitionCostsDisposition_2_Q2_USD":31400.0,"ConvertibleDebtNoncurrent_0_Q2_USD":87300.0,"CapitalLeaseObligationsCurrent_0_Q2_USD":3500.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":668400.0,"CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_0_Q2_USD":10900.0,"CommonStockSharesIssued_0_Q2_shares":74133722.0,"DeferredRevenueRefundPayments1_2_Q2_USD":334000.0,"DeferredRevenueRevenueRecognized1_2_Q2_USD":5000000.0,"OperatingLeaseLiability_0_Q2_USD":3879400.0,"DeferredCosts_0_Q2_USD":321700.0,"Liabilities_0_Q2_USD":16048100.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":326600.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":25761834.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":5207400.0,"InterestPayableCurrentAndNoncurrent_0_Q2_USD":1000.0,"PrepaidExpenseCurrent_0_Q2_USD":455700.0,"IncomeTaxExpenseBenefit_1_Q2_USD":200.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2600.0,"CommonStockValue_0_Q2_USD":74100.0,"Revenues_1_Q2_USD":334000.0,"Revenues_2_Q2_USD":334000.0,"LongTermNotesPayable_0_Q2_USD":87300.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":2841600.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-985700.0,"Assets_0_Q2_USD":20270700.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":14044400.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":4089400.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":15946200.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":49300.0,"DeferredRevenueNoncurrent_0_Q2_USD":3422000.0,"ConvertibleDebtCurrent_0_Q2_USD":352600.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":3900.0,"ProceedsFromNotesPayable_2_Q2_USD":224400.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-3645000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-7107600.0,"DeferredCostsCurrentAndNoncurrent_0_Q2_USD":438600.0,"OtherAssetsNoncurrent_0_Q2_USD":47800.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":15399500.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3540900.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":2358200.0,"ShareBasedCompensation_1_Q2_USD":410900.0,"ShareBasedCompensation_2_Q2_USD":1085500.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3403000.0,"DividendsPreferredStock_2_Q2_USD":683000.0,"PaymentsToAcquireMachineryAndEquipment_2_Q2_USD":98800.0,"CapitalLeaseObligationsNoncurrent_0_Q2_USD":1300.0,"DividendsPreferredStockCash_1_Q2_USD":347200.0,"PreferredStockDividendsAndOtherAdjustments_2_Q2_USD":683000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q2_USD":347200.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1087400.0,"NotesAndLoansPayableCurrent_0_Q2_USD":352600.0,"InterestIncomeExpenseNet_2_Q2_USD":-7100.0,"InterestIncomeExpenseNet_1_Q2_USD":-3900.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":410900.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1803000.0,"ProceedsFromWarrantExercises_2_Q2_USD":84600.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-208332000.0,"ConvertibleNotesPayable_0_Q2_USD":438900.0,"DeferredRevenueCurrent_0_Q2_USD":1244000.0,"AccountsPayableCurrent_0_Q2_USD":1176400.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":455700.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":16400.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0854,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-176700.0,"AdditionalPaidInCapital_0_Q2_USD":216444600.0,"PrepaidInsurance_0_Q2_USD":277800.0,"DeferredPolicyAcquisitionCostsAdditions_2_Q2_USD":470000.0,"CapitalLeasesBalanceSheetAssetsByMajorClassNet_0_Q2_USD":3800.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":257600.0,"NetIncomeLoss_2_Q2_USD":-6424600.0,"LiabilitiesCurrent_0_Q2_USD":3301900.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":78200.0,"DeferredCostsCurrent_0_Q2_USD":116900.0,"OtherIncome_1_Q2_USD":0.0,"DeferredRevenue_0_Q2_USD":4666000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":12961300.0,"RepaymentsOfNotesPayable_2_Q2_USD":164100.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1328000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":789000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-91500.0,"CommonStockSharesAuthorized_0_Q2_shares":175000000.0,"OperatingIncomeLoss_2_Q2_USD":-6415500.0,"OperatingIncomeLoss_1_Q2_USD":-3293700.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-6422000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-3297600.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-149700.0,"CommonStockOtherSharesOutstanding_0_Q2_shares":74133722.0,"OperatingLeaseCost_1_Q2_USD":207300.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":20270700.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1345000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":338500.0,"OperatingExpenses_2_Q2_USD":6749500.0,"OperatingExpenses_1_Q2_USD":3627700.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.12,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.05,"ProfitLoss_1_Q2_USD":-3297800.0,"DeferredOfferingCosts_0_Q2_USD":268500.0,"StockholdersEquity_0_Q2_USD":4222600.0,"OtherIncome_2_Q2_USD":600.0,"OperatingLeaseCost_2_Q2_USD":420100.0,"ConvertibleDebt_0_Q2_USD":439900.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]